BIONANO GENOMICS INC (BNGO) Forecast, Price Target & Analyst Ratings
NASDAQ:BNGO • US09075F4046
1.13 USD
0 (0%)
Last: Mar 11, 2026, 01:41 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BIONANO GENOMICS INC (BNGO).
Forecast Snapshot
Consensus Price Target
$7.65
+ 576.99% Upside
Next Earnings Forecast
Release DateMar 30, 2026
PeriodQ4 / 2025
EPS Estimate-$1.43
Revenue Estimate8.01M
ChartMill Buy Consensus
80.00%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$7.65
Upside
+ 576.99%
From current price of $1.13 to mean target of $7.65, Based on 9 analyst forecasts
Low
$7.07
Median
$7.65
High
$8.40
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
9 Wall Street analysts provided a forecast for the next 12 months for BNGO. The average price target is 7.65 USD. This implies a price increase of 576.99% is expected in the next year compared to the current price of 1.13.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
80.00%
BNGO was analyzed by 9 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about BNGO.
In the previous month the buy percentage consensus was at a similar level.
BNGO was analyzed by 9 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-11-24 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-08-18 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-05-20 | Maxim Group | Upgrade | Hold -> Buy |
| 2025-04-09 | HC Wainwright & Co. | Initiate | Buy |
| 2025-04-02 | ScotiaBank | Maintains | Sector Perform -> Sector Perform |
| 2024-11-15 | Ladenburg Thalmann | Downgrade | Buy -> Neutral |
| 2024-09-10 | BTIG | Downgrade | Buy -> Neutral |
| 2024-08-28 | ScotiaBank | Downgrade | Sector Outperform -> Sector Perform |
| 2024-05-16 | BTIG | Maintains | Buy -> Buy |
| 2024-03-07 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2023-11-13 | Maxim Group | Downgrade | Buy -> Hold |
| 2023-08-10 | BTIG | Maintains | Buy -> Buy |
| 2023-05-25 | EF Hutton | Initiate | Buy |
| 2023-05-18 | BTIG | Maintains | Buy -> Buy |
| 2023-02-06 | Oppenheimer | Maintains | Outperform |
| 2023-01-05 | ScotiaBank | Initiate | Sector Outperform |
| 2022-04-07 | BTIG | Maintains | Buy |
| 2021-06-16 | BTIG | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
Release DateMar 30, 2026
PeriodQ4 / 2025
EPS Estimate-$1.43
Revenue Estimate8.01M
Revenue Q2Q-1.87%
EPS Q2Q90.98%
Number of Analysts5
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
0.86%
EPS (1 Month)
0.00%
EPS (3 Months)
0.24%
Next Earnings Summary
BNGO is expected to report earnings on 3/30/2026. The consensus EPS estimate for the next earnings is -1.43 USD and the consensus revenue estimate is 8.01M USD.
The next earnings revenue estimate has been revised upward by 0.86% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 27.8M 54.62% | 36.116M 29.91% | 30.776M -14.79% | 28.79M -6.45% | 35.776M 24.27% | 52.959M 48.03% | 66.881M 26.29% | 81.689M 22.14% | 99.613M 21.94% | 121.3M 21.77% | 147.53M 21.62% | 166.71M 13.00% | |
| EBITDA YoY % growth | -120.06M -66.22% | -124.053M -3.33% | -62.052M 49.98% | -18.36M 70.41% | -10.2M 44.44% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -129.9M -71.83% | -137.965M -6.21% | -76.278M 44.71% | -32.482M 57.42% | -27.931M 14.01% | -19.572M 29.93% | -9.571M 51.10% | 6.42M 167.08% | 17.943M 179.49% | 32.078M 78.78% | 49.374M 53.92% | 61.71M 24.98% | |
| Operating Margin | -467.27% | -382.01% | -247.85% | -112.82% | -78.07% | -36.96% | -14.31% | 7.86% | 18.01% | 26.45% | 33.47% | 37.02% | |
| EPS YoY % growth | -276.00 -81.10% | -231.00 16.30% | -83.63 63.80% | -6.43 92.31% | -3.64 43.39% | -1.24 65.83% | -0.52 58.20% | 0.35 166.67% | 0.98 182.35% | 1.73 77.08% | 2.66 53.53% | 3.24 21.84% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.43 90.98% | -1.05 8.43% | -0.91 54.04% | -0.74 53.17% | -0.64 55.48% |
| Revenue Q2Q % growth | 8.01M -1.87% | 8.039M 24.50% | 8.687M 29.02% | 9.133M 23.97% | 9.883M 23.38% |
| EBITDA Q2Q % growth | -4.08M -268.39% | -4.08M 31.77% | -3.06M -6.10% | -2.04M -70.71% | -1.02M 75.00% |
| EBIT Q2Q % growth | -7.558M 35.97% | -6.933M 18.09% | -6.304M 19.18% | -6.319M 25.99% | -5.791M 23.38% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
25.68%
EPS Next 5 Year
14.92%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
21.70%
Revenue Next 5 Year
22.69%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
BIONANO GENOMICS INC / BNGO Forecast FAQ
Can you provide the average price target for BIONANO GENOMICS INC stock?
9 analysts have analysed BNGO and the average price target is 7.65 USD. This implies a price increase of 576.99% is expected in the next year compared to the current price of 1.13.
Can you provide the upcoming earnings date for BIONANO GENOMICS INC?
BIONANO GENOMICS INC (BNGO) will report earnings on 2026-03-30, after the market close.
Can you provide the consensus estimates for BIONANO GENOMICS INC next earnings?
The consensus EPS estimate for the next earnings of BIONANO GENOMICS INC (BNGO) is -1.43 USD and the consensus revenue estimate is 8.01M USD.
What is the expected long term growth rate for BIONANO GENOMICS INC (BNGO)?
The expected long term growth rate for BIONANO GENOMICS INC (BNGO) is 21.7%.